Programs

Scroll to explore

Scroll back top

GPCR target for metabolic diseases

23 February 2022

Precision Medicine and Immunotherapy of Sarcoma

A2aR/A2bR antagonist

EP4 receptor antagonist ( DT-9081 )

Anti-CCR8 antibody

26 February 2020

Undisclosed GPCR targets

Multi-target collaboration for CNS

mGluR4/7/8 PAM

NPFFR antagonist

22 November 2021

mGluR3 PAM